Literature DB >> 21177389

Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat model.

Ritika Uppal1, Ciprian Catana, Ilknur Ay, Thomas Benner, A Gregory Sorensen, Peter Caravan.   

Abstract

PURPOSE: To image thrombus by using magnetic resonance (MR) imaging and positron emission tomography (PET) simultaneously in a rat arterial thrombus model with a dual PET/MR probe.
MATERIALS AND METHODS: Animal studies were approved by the institutional animal use committee. A dual PET/MR probe was synthesized by means of partial exchange of gadolinium for copper 64 ((64)Cu) in the fibrin-targeted MR probe EP-2104R. A preformed 25-mm thrombus was injected into the right internal carotid artery of a rat. Imaging was performed with a clinical 3.0-T MR imager with an MR-compatible human PET imager. Rats (n = 5) were imaged prior to and after systemic administration of the dual probe by using simultaneous PET/MR. The organ distribution of (64)Cu and gadolinium was determined ex vivo (n = 8), 2 hours after injection by using well counting and inductively coupled plasma mass spectrometry, respectively. Signal intensity ratios (SIRs) between the thrombus-containing and contralateral vessel were computed from PET images and MR data before and after probe administration.
RESULTS: The dual probe was synthesized with greater than 98% radiochemical purity. Thrombus enhancement was observed in all five animals at both MR (SIR([postprobe])/SIR([preprobe]) = 1.71 ± 0.35, P = .0053) and PET (SIR = 1.85 ± 0.48, P = .0087) after injection of the dual PET/MR probe. Ex vivo analysis at 2 hours after injection showed the highest (64)Cu and gadolinium concentrations, after the excretory organs (kidney and liver), to be in the thrombus.
CONCLUSION: A fibrin-targeted dual PET/MR probe enables simultaneous, direct MR and PET imaging of thrombus. © RSNA, 2010.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21177389      PMCID: PMC3042637          DOI: 10.1148/radiol.10100881

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  36 in total

1.  AMIDE: a free software tool for multimodality medical image analysis.

Authors:  Andreas Markus Loening; Sanjiv Sam Gambhir
Journal:  Mol Imaging       Date:  2003-07       Impact factor: 4.488

2.  Molecular magnetic resonance imaging of atrial clots in a swine model.

Authors:  Elmar Spuentrup; Bernd Fausten; Sylvia Kinzel; Andrea J Wiethoff; Rene M Botnar; Philip B Graham; Stephan Haller; Marcus Katoh; Edward C Parsons; Warren J Manning; Thomas Busch; Rolf W Günther; Arno Buecker
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

3.  Molecular MRI of intracranial thrombus in a rat ischemic stroke model.

Authors:  Ritika Uppal; Ilknur Ay; Guangping Dai; Young Ro Kim; A Gregory Sorensen; Peter Caravan
Journal:  Stroke       Date:  2010-04-15       Impact factor: 7.914

4.  Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.

Authors:  Elmar Spuentrup; Arno Buecker; Marcus Katoh; Andrea J Wiethoff; Edward C Parsons; Rene M Botnar; Robert M Weisskoff; Philip B Graham; Warren J Manning; Rolf W Günther
Journal:  Circulation       Date:  2005-02-28       Impact factor: 29.690

5.  A rat model of focal embolic cerebral ischemia.

Authors:  R L Zhang; M Chopp; Z G Zhang; Q Jiang; J R Ewing
Journal:  Brain Res       Date:  1997-08-22       Impact factor: 3.252

6.  Bimodal MR-PET agent for quantitative pH imaging.

Authors:  Luca Frullano; Ciprian Catana; Thomas Benner; A Dean Sherry; Peter Caravan
Journal:  Angew Chem Int Ed Engl       Date:  2010-03-22       Impact factor: 15.336

7.  A combined PET/CT scanner for clinical oncology.

Authors:  T Beyer; D W Townsend; T Brun; P E Kinahan; M Charron; R Roddy; J Jerin; J Young; L Byars; R Nutt
Journal:  J Nucl Med       Date:  2000-08       Impact factor: 10.057

8.  In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.

Authors:  René M Botnar; Arno Buecker; Andrea J Wiethoff; Edward C Parsons; Marcus Katoh; George Katsimaglis; Robert M Weisskoff; Randall B Lauffer; Philip B Graham; Rolf W Gunther; Warren J Manning; Elmar Spuentrup
Journal:  Circulation       Date:  2004-07-06       Impact factor: 29.690

9.  Comparative in vivo stability of copper-64-labeled cross-bridged and conventional tetraazamacrocyclic complexes.

Authors:  C Andrew Boswell; Xiankai Sun; Weijun Niu; Gary R Weisman; Edward H Wong; Arnold L Rheingold; Carolyn J Anderson
Journal:  J Med Chem       Date:  2004-03-11       Impact factor: 7.446

10.  Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.

Authors:  M F Tweedle; P Wedeking; K Kumar
Journal:  Invest Radiol       Date:  1995-06       Impact factor: 6.016

View more
  36 in total

1.  Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging.

Authors:  Andrew F Kolodziej; Shrikumar A Nair; Philip Graham; Thomas J McMurry; Robert C Ladner; Charles Wescott; Daniel J Sexton; Peter Caravan
Journal:  Bioconjug Chem       Date:  2012-02-09       Impact factor: 4.774

Review 2.  Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.

Authors:  Thibaut Quillard; Peter Libby
Journal:  Circ Res       Date:  2012-07-06       Impact factor: 17.367

3.  Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats.

Authors:  Francesco Blasi; Bruno L Oliveira; Tyson A Rietz; Nicholas J Rotile; Pratap C Naha; David P Cormode; David Izquierdo-Garcia; Ciprian Catana; Peter Caravan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-13       Impact factor: 8.311

Review 4.  Current status and future role of brain PET/MRI in clinical and research settings.

Authors:  P Werner; H Barthel; A Drzezga; O Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

5.  Radiation Dosimetry of the Fibrin-Binding Probe ⁶⁴Cu-FBP8 and Its Feasibility for PET Imaging of Deep Vein Thrombosis and Pulmonary Embolism in Rats.

Authors:  Francesco Blasi; Bruno L Oliveira; Tyson A Rietz; Nicholas J Rotile; Helen Day; Pratap C Naha; David P Cormode; David Izquierdo-Garcia; Ciprian Catana; Peter Caravan
Journal:  J Nucl Med       Date:  2015-05-14       Impact factor: 10.057

Review 6.  The role of molecular imaging in diagnosis of deep vein thrombosis.

Authors:  Sina Houshmand; Ali Salavati; Søren Hess; Mudalsha Ravina; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-08-15

7.  In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe.

Authors:  Ilknur Ay; Francesco Blasi; Tyson A Rietz; Nicholas J Rotile; Sreekanth Kura; Anna Liisa Brownell; Helen Day; Bruno L Oliveira; Richard J Looby; Peter Caravan
Journal:  Circ Cardiovasc Imaging       Date:  2014-04-28       Impact factor: 7.792

8.  Fibrin-targeted PET probes for the detection of thrombi.

Authors:  Katie L Ciesienski; Yan Yang; Ilknur Ay; Daniel B Chonde; Galen S Loving; Tyson A Rietz; Ciprian Catana; Peter Caravan
Journal:  Mol Pharm       Date:  2013-01-30       Impact factor: 4.939

Review 9.  PET and MR imaging: the odd couple or a match made in heaven?

Authors:  Ciprian Catana; Alexander R Guimaraes; Bruce R Rosen
Journal:  J Nucl Med       Date:  2013-03-14       Impact factor: 10.057

10.  Multimodal Molecular Imaging Reveals High Target Uptake and Specificity of 111In- and 68Ga-Labeled Fibrin-Binding Probes for Thrombus Detection in Rats.

Authors:  Bruno L Oliveira; Francesco Blasi; Tyson A Rietz; Nicholas J Rotile; Helen Day; Peter Caravan
Journal:  J Nucl Med       Date:  2015-08-06       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.